FrancophonIA/ELRC3.0 huggingface dataset:
English: Bone disorders reported were genu valgum, leg pain and hyperextensive joints, osteopenia, compression fractures, and scoliosis.
Danish: Der har været rapporteret følgende knogle forstyrrelser: genu valgum (kalveknæ), smerter i benene, hyperekstension af led, osteopeni, kompressionsbrud samt skoliose.
English: HOW TO STORE CYSTAGON
Danish: SÅDAN OPBEVARER DE/DU CYSTAGON
English: HOW TO USE CYSTAGON
Danish: SÅDAN SKAL DE/DU TAGE CYSTAGON
English: Capsule content: microcrystalline cellulose, pregelatinized starch, magnesium stearate/sodium lauryl sulfate, colloidal silicon dioxide, croscarmellose sodium Capsule shell: gelatin, titanium dioxide,
Danish: Cellulose mikrokrystallinsk, stivelse pregelatineret, magnesiumstearat/natriumlaurilsulfat, silica, kolloid dioxid, natrium carboxymethylcellulose,
English: Marketing Authorisation Holder Recordati Rare Diseases Immeuble “Le Wilson” 70, Avenue du Général de Gaulle F-92800 Puteaux
Danish: Indehaveren af markedsføringstilladelsen Recordati Rare Diseases Immeuble “Le Wilson” 70, Avenue du Général de Gaulle F-92800 Puteaux
English: CYSTAGON should not be used during pregnancy, particularly during the first trimester, unless clearly necessary (see section 4.6 and section 5.3), as it is teratogenic in animals.
Danish: CYSTAGON bør ikke anvendes under graviditet, især ikke under første trimester, medmindre det er klart nødvendigt (se pkt.
English: Uncommon: Joint hyperextension, leg pain, genu valgum, osteopenia, compression fracture, scoliosis.
Danish: Usædvanlige: led hyperekstension, smerter i benene, genu valgum (kalveknæ), osteopeni, kompressionsbrud, skoliose
English: CYSTAGON 50 mg Hard Capsules CYSTAGON 150 mg Hard Capsules Cysteamine bitartrate (mercaptamine bitartrate)
Danish: CYSTAGON 50 mg, hårde kapsler CYSTAGON 150 mg, hårde kapsler Cysteaminbitartrate (mercaptaminebitartrate)
English: Capsule content: microcrystalline cellulose, pregelatinized starch, magnesium stearate/sodium lauryl sulfate, colloidal silicon dioxide, croscarmellose sodium Capsule shell: gelatin, titanium dioxide, black ink on hard capsules containing E172
Danish: - De øvrige indholdsstoffer er mikrokrystallinsk cellulose, pregelatineret stivelse, magnesiumstearat/natriumlaurylsulfat, silica kolloid, natriumcarboxymethylcellulose, kapselmateriale: gelatine, titaniumdioxid, sort blæk på de hårde kapsler (E172).
English: Hypersensitivity to the active substance or to any of the excipients The use of CYSTAGON is contra-indicated during breast-feeding.
Danish: Overfølsomhed over for det aktive stof eller over for et eller flere af hjælpestofferne.
English: BEFORE YOU USE CYSTAGON
Danish: DET SKAL DE/DU VIDE, FØR DE/DU BEGYNDER AT TAGE CYSTAGON
English: Your or your child's doctor will arrange for the blood tests to be done.
Danish: Deres/din læge vil sørge for dette.
English: However, due to the results of animal studies in breast-feeding mothers and neonates (see section 5.3), breast-feeding is contraindicated in women taking CYSTAGON.
Danish: Grundet resultaterne ved dyreundersøgelser hos ammende mødre og nyfødte (se pkt.
English: EU/1/97/039/001 (100 hard capsules per bottle), EU/1/97/039/002 (500 hard capsules per bottle).
Danish: EU/1/97/039/001 (100 hårde kapsler pr. flaske), EU/1/97/039/002 (500 hårde kapsler pr. flaske).
English: Each hard capsule contains 50 mg of cysteamine (as mercaptamine bitartrate) .
Danish: Hver hård kapsel indeholder 50 mg cysteamin (som mercaptamin bitartrat).
English: EU/1/97/039/003 - 100 hard capsules EU/1/97/039/004 - 500 hard capsules
Danish: EU/1/97/039/003 - 100 hårde kapsler EU/1/97/039/004 - 500 hårde kapsler
English: - This medicine has been prescribed for you.
Danish: - Lægen har ordineret CYSTAGON til Dem/dig personligt.
English: EU/1/97/039/003 (100 hard capsules per bottle), EU/1/97/039/004 (500 hard capsules per bottle).
Danish: EU/1/97/039/003 (100 hårde kapsler pr. flaske), EU/1/97/039/004 (500 hårde kapsler pr. flaske).
English: Pregnancy
Danish: PRODUKTRESUME
English: EU/1/97/039/001 - 100 hard capsules EU/1/97/039/002 - 500 hard capsules
Danish: EU/1/97/039/001 - 100 hårde kapsler EU/1/97/039/002 - 500 hårde kapsler
English: Hard Capsule White, opaque hard capsules with CYSTA 50 on the body and MYLAN on the cap.
Danish: Hård kapsel Hvide, ugennemsigtige hårde kapsler med CYSTA 50 på selve glasset og MYLAN på låget.
English: Each hard capsule contains 150 mg of cysteamine (as mercaptamine bitartrate) .
Danish: Hver hård kapsel indeholder 150 mg cysteamin (som mercaptaminbitartrat).
English: Recordati Rare Diseases Immeuble “Le Wilson” 70, Avenue du Général de Gaulle F-92800 Puteaux France
Danish: Recordati Rare Diseases Immeuble ”Le Wilson” 70, Avenue du Général de Gaulle F-92800 Puteaux Frankrig
English: CYSTAGON 50 mg hard capsules
Danish: CYSTAGON 50 mg hårde kapsler
English: CYSTAGON 150 mg hard capsules
Danish: CYSTAGON 150 mg hårde kapsler
English: Hard Capsule White, opaque hard capsules with CYSTAGON 150 on the body and MYLAN on the cap.
Danish: Hård kapsel Hvide, ugennemsigtige hårde kapsler med CYSTAGON 150 på selve glasset og MYLAN på låget.
English: Always use CYSTAGON exactly as your doctor or your child's doctor has told you.
Danish: Tag altid CYSTAGON nøjagtigt efter lægens anvisning.
English: CYSTAGON 150 mg hard capsules Cysteamine
Danish: CYSTAGON 150 mg hårde kapsler Cysteamin
English: What CYSTAGON looks like and contents of the pack Hard Capsules - Cystagon 50 mg: white, opaque hard capsules with CYSTA 50 on the body and MYLAN on the cap.
Danish: Hård kapsel - Cystagon 50 mg: hvide, ugennemsigtige hårde kapsler med CYSTA 50 på selve glasset og MYLAN på låget.
English: However, due to the results of animal studies in breast-feeding mothers and neonates (see section 5.3), breast-feeding is contra-indicated in women taking CYSTAGON.
Danish: 5.3), er amning imidlertid kontraindikeret hos kvinder, der får CYSTAGON.
English: In this leaflet:
Danish: NN:
English: OUTER CARTON CYSTAGON 150 mg x 100 hard capsules OUTER CARTON CYSTAGON 150 mg x 500 hard capsules
Danish: YDRE EMBALLAGE CYSTAGON 150 mg x 100 hårde kapsler YDRE EMBALLAGE CYSTAGON 150 mg x 500 hårde kapsler
English: OUTER CARTON CYSTAGON 50 mg x 100 hard capsules OUTER CARTON CYSTAGON 50 mg x 500 hard capsules
Danish: YDRE EMBALLAGE CYSTAGON 50 mg x 100 hårde kapsler YDRE EMBALLAGE CYSTAGON 50 mg x 500 hårde kapsler
English: BOTTLE LABEL CYSTAGON 150 mg x 100 hard capsules BOTTLE LABEL CYSTAGON 150 mg x 500 hard capsules
Danish: INDRE EMBALLAGE CYSTAGON 150 mg x 100 hårde kapsler INDRE EMBALLAGE CYSTAGON 150 mg x 500 hårde kapsler
English: CYSTAGON 50 mg hard capsules Cysteamine
Danish: CYSTAGON 50 mg hårde kapsler Cysteamin
English: BOTTLE LABEL CYSTAGON 50 mg x 100 hard capsules BOTTLE LABEL CYSTAGON 50 mg x 500 hard capsules
Danish: INDRE EMBALLAGE CYSTAGON 50 mg x 100 hårde kapsler INDRE EMBALLAGE CYSTAGON 50 mg x 500 hårde kapsler
English: - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
Danish: - Tal med lægen eller apoteket, hvis en bivirkning bliver værre, eller De/du får bivirkninger,
English: Strength Pharmaceutical Form
Danish: Særnavn Styrke Lægemiddelform Administration Emballage Indhold
English: MA (EU) number
Danish: EU nummer.
English: Avoid contact with the eyes and skin.
Danish: Undgå kontakt med øjnene og huden.
English: Interim monitoring visit:
Danish: Interim monitoreringsbesøg:
English: This is particularly important when injecting small volumes.
Danish: Det er især vigtigt, når der injiceres små mængder.
English: Before starting treatment with the veterinary medicinal product, it is important that Addison's disease has been definitively diagnosed.
Danish: Inden behandlingen med det veterinære lægemiddel påbegyndes, er det vigtigt, at Addisons sygdom er blevet definitivt diagnosticeret.
English: The concurrent administration of glucocorticoids may contribute to these signs.
Danish: Samtidig administration af glucokortikoider kan bidrage til disse tegn.
English: • If the dog is both clinically normal and has a normal Na
Danish: • Hvis hunden er både klinisk normal og har et normalt Na
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton and the vial after EXP.
Danish: Brug ikke dette veterinærlægemiddel efter den udløbsdato, der står på kartonen og hætteflasken efter EXP.
English: Pancreas disorders have been reported very rarely following use of Zycortal.
Danish: Forstyrrelser i pankreas har i meget sjældne tilfælde være rapporteret efter brug af Zycortal.
English: EXP {month/year} Once broached, use by __/__/__
Danish: EXP {måned/år} Efter anbrud, anvendes inden __/__/__
English: Do not administer Dose 2 on Day 10.
Danish: Administrer ikke dosis 2 på dag 10.
English: A. LABELLING
Danish: A. ETIKTTERING
English: In case of signs of overdose, the dog should be treated symptomatically, and subsequent doses reduced.
Danish: I tilfælde af overdosering bør hunden behandles symptomatisk og efterfølgende doser reduceres.
English: Prior to a stressful situation, consider temporarily increasing the dose of glucocorticoid.
Danish: Inden en stressende situation kan det overvejes midlertidigt at øge dosis af glukokortikoid.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - Rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Danish: Hyppigheden af bivirkninger er defineret som: - Meget almindelig (flere end 1 ud af 10 behandlede dyr, der viser bivirkninger i løbet af en behandling) - Almindelige (flere end 1, men færre end 10 dyr af 100 behandlede dyr) - Ikke almindelige (flere end 1, men færre end 10 dyr af 1.000 behandlede dyr) - Sjældne (flere end 1, men færre end 10 dyr ud af 10.000 behandlede dyr) - Meget sjælden (færre end 1 dyr ud af 10.000 behandlede dyr, herunder isolerede rapporter).
English: In case of accidental spillage onto the skin or eyes, wash the affected area with water.
Danish: I tilfælde af kontakt med huden eller øjnene ved hændeligt uheld skal det berørte område vaskes med vand.
English: Zycortal is an opaque white suspension.
Danish: Zycortal er en gennemsigtig, hvid suspension.
English: Therefore, use only according to the benefit/risk assessment by the responsible veterinarian.
Danish: Må derfor kun anvendes i overensstemmelse med den ansvarlige dyrlæges vurdering af risk-benefit-forholdet.
English: Marketing authorisation holder: Dechra Regulatory B.V.
Danish: Indehaver af markedsføringstilladelsen: Dechra Regulatory B.V.
English: Zycortal is intended for long term administration at intervals and doses dependent upon individual response.
Danish: Zycortal er beregnet til langvarig administration ved intervaller og doser, der afhænger af det enkelte respons.
English: ≥ 24 to < 27
Danish: ≥ 24 til < 27
English: Once the optimal dose and dosing interval have been determined, maintain the same regimen.
Danish: Når den optimale dosis og doseringsinterval er bestemt, opretholdes det samme regime.
English: This product may cause adverse effects on male reproductive organs and, as a result, fertility.
Danish: Lægemidlet kan have negativ indvirkning på de mandlige kønsorganer og som et resultat deraf, fertiliteten.
English: This product may cause adverse developmental effects on unborn children and neonates.
Danish: Lægemidlet kan have negativ indvirkning på udviklingen af ufødte børn og nyfødte.
English: Second dose of Zycortal:
Danish: Anden dosis af Zycortal:
English: This product may cause pain and swelling at the injection site if accidentally self-administered.
Danish: Lægemidlet kan forårsage smerter og hævelse på injektionsstedet i tilfælde af selvindgivelse ved hændeligt uheld.
English: Methylcellulose Sodium carboxymethylcellulose Polysorbate 60
Danish: Methylcellulose Natriumcarboxymethylcellulose Polysorbat 60
English: 32 to < 34
Danish: 32 til < 34
English: Use an appropriately graduated syringe to accurately administer the required dose volume.
Danish: Brug en passende gradueret sprøjte til at indgive den påkrævede dosismængde nøjagtigt.
English: Zycortal replaces the mineralocorticoid hormones only.
Danish: Zycortal erstatter kun mineralokortikoider.
English: Polyuria and polydipsia may be observed.
Danish: Polyuri og polydipsi kan observeres.
English: Pharmacotherapeutic group: corticosteroids for systemic use, mineralocorticoids ATCvet code: QH02AA03
Danish: Farmakoterapeutisk gruppe: Kortikosteroider til systemisk anvendelse, mineralokortikoider ATCvet-kode: QH02AA03
English: Subsequent doses and long term management:
Danish: Efterfølgende doser og langtidsbehandling
English: Opaque white suspension.
Danish: Uigennemsigtig, hvid suspension.
English: Dogs with combined glucocorticoid and mineralocorticoid deficiency should also receive a glucocorticoid such as prednisolone in accordance with standard texts.
Danish: Hunde med kombineret glukokortikoid- og mineralokortikoidmangel bør også få en glukokortikoid som f.eks. prednisolon i overensstemmelse med standard tekster.
English: For use as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison's disease).
Danish: Til anvendelse som erstatningsbehandling for mineralokortikoidmangel hos hunde med primær hypoadrenokorticisme (Addisons sygdom).
English: If the dog's clinical signs have worsened or not resolved, adjust the dose of glucocorticoid and/or investigate other causes of the clinical signs.
Danish: Hvis hundens kliniske tegn forværres eller ikke afhjælpes, skal glukokortikoiddosen justeres og/eller andre årsager til de kliniske tegn skal undersøges.
English: Evaluate the electrolytes every 5-9 days until the Na⁺/K⁺ ratio is < 32, and then administer 2.2 mg/kg of Zycortal.
Danish: Evaluer elektrolytterne hver 5-9 dage, indtil Na⁺/K⁺-forholdet er < 32, og administrer dernæst 2,2 mg/kg Zycortal.
English: Any dog presenting with severe hypovolaemia, dehydration, prerenal azotaemia and inadequate tissue perfusion (also known as “Addisonian crisis”) must be rehydrated with intravenous fluid (saline) therapy before starting treatment with the veterinary medicinal product.
Danish: En hund med svær hypovolæmi, dehydrering, prærenal azotæmi og utilstrækkelig vævsperfusion (også kendt som “Addison krise”) skal rehydreres med intravenøs væske (fysiologisk saltvand), inden behandlingen med det veterinære lægemiddel påbegyndes.
English: Hypertension has been observed in dogs receiving 20 mg/kg of desoxycortone pivalate.
Danish: Hypertension er blevet observeret hos hunde, der får 20 mg/kg desoxycorton pivalat.
English: The safety of the veterinary medicinal product has not been established during breeding, pregnancy or lactation.
Danish: Lægemidlets sikkerhed under avling, drægtighed eller laktation er ikke fastlagt.
English: 27 to < 32
Danish: 27 til < 32
English: If the dog develops abnormal clinical signs or Na⁺ or K⁺ serum concentrations, use the following guidelines for subsequent doses:
Danish: Hvis hunden udvikler unormale kliniske tegn eller Na⁺- eller K⁺-serumkoncentrationer, bruges følgende retningslinier til efterfølgende doser:
English: Do not store above 30 °C.
Danish: Må ikke opbevares over 30°C.
English: Do not store above 30 C.
Danish: Må ikke opbevares over 30 C.
English: • Clinical signs of polyuria/polydipsia: Decrease the glucocorticoid dose first.
Danish: • Kliniske tegn på polyuri/polydipsi: Nedsæt først dosis af glukokortikoid.
English: 5531 AE Bladel The Netherlands
Danish: 5531 AE Bladel Holland
English: Use with caution in dogs with congestive heart disease, severe renal disease, primary hepatic failure or oedema.
Danish: Anvendes med forsigtighed til hunde med kongestiv hjertesygdom, svær nyresygdom, primær leversvigt eller ødem.
English: Type I glass vial (containing 4 ml) with a coated chlorobutyl rubber stopper and aluminium seal with a plastic flip-off cap.
Danish: Hætteglas (type I-glas) (indeholdende 4 ml) med coated prop af chlorobutylgummi og aluminiumforsegling med et snaplåg af plast.
English: As expected from the pharmacodynamic effects, escalating doses of desoxycortone are associated with a dose-related trend for increased serum sodium, and decreased blood urea nitrogen, serum potassium and urine specific gravity.
Danish: Som forventet fra de farmakodynamiske virkninger er eskalerende doser af desoxycorton forbundet med en dosisrelateret tendens til øget serum-natrium og nedsat blodureanitrogen, serum-kalium og urinvægtfylde.
English: Shelf life after first opening the container: 120 days.
Danish: Opbevaringstid efter første åbning af beholderen: 120 dage.
English: • Clinical signs of depression, lethargy, vomiting, diarrhoea or weakness: Increase the glucocorticoid dose.
Danish: • Kliniske tegn på depression, sløvhed, opkastning, diarre eller svækkelse: Øg dosis af glukokortikoid.
English: Polyuria, polydipsia may be observed.
Danish: Polyuri, polydipsi kan observeres.
English: In a clinical trial, very common adverse reactions were polydipsia and polyuria.
Danish: I et klinisk studie var meget almindelige bivirkninger polydipsi og polyuri.
English: Manufacturer responsible for batch release: Dales Pharmaceuticals Limited Snaygill Industrial Estate Keighley Road
Danish: Fremstiller ansvarlig for batchfrigivelse: Dales Pharmaceuticals Limited Snaygill Industrial Estate Keighley Road
English: Desoxycortone is a corticosteroid with primarily mineralocorticoid activity, similar to aldosterone.
Danish: Desoxycorton er et kortikosteroid med primær mineralokortikoidaktivitet magen til aldosteron.
English: Prior to use, gently shake the vial to resuspend the product.
Danish: Inden brug rystes hætteglasset forsigtigt for at resuspendere lægemidlet.
English: Shelf life after first opening the immediate packaging: 120 days.
Danish: Opbevaringstid efter første åbning af den indre emballage: 120 dage.
English: In a clinical trial, very common adverse reactions were polydipsia (excessive drinking) and polyuria (excessive urination).
Danish: I et klinisk studie var meget almindelige bivirkninger polydipsi (øget væskeindtag) og polyuri (øget urinering).
English: In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Danish: I tilfælde af selvindgivelse ved hændeligt uheld skal der straks søges lægehjælp, og indlægssedlen eller etiketten bør vises til lægen.
English: After subcutaneous administration of desoxycortone pivalate at a dosage of 11 mg/kg body weight (five times the recommended dosage), the plasma half-life (mean ± standard deviation) is approximately 17 ± 7 days, with a maximum concentration (Cmax) of 13.2 ± 5 ng/ml, and time to maximum concentration (Tmax) of 10 ± 3.5 days.
Danish: Efter subkutan administration af desoxycorton pivalat ved en dosering på 11 mg/kg kropsvægt (fem gange den anbefalede dosering), er plasmahalveringstiden (middel ± standardafvigelse) ca. 17 ± 7 dage med en maksimal koncentration (Cmax) på 13,2 ± 5 ng/ml, og tid til maksimal koncentration (Tmax) på 10 ± 3,5 dage.
English: In the kidney, desoxycortone causes sodium and chloride ion retention, and hydrogen and potassium ion excretion, creating an osmotic gradient.
Danish: I nyren forårsager desoxycorton natrium- og chloridionretention og udskillelse af hydrogen- og kaliumion, hvorved der dannes en osmotisk gradient.
English: If the dog is clinically normal and the Day 25 Na⁺/K⁺ ratio is > 32, it is possible to prolong the dosing interval instead of adjusting the dose as described in Table 1.
Danish: Hvis hunden er klinisk normal og Na⁺/K⁺-forholdet på dag 25 er > 32, er det muligt at forlænge doseringsintervallet i stedet for at justere dosis som beskrevet i Tabel 1.
English: When given to dogs at three to five times the recommended dose, injection site reactions characterised by erythema and oedema occurred.
Danish: Når lægemidlet blev givet til hunde ved tre til fem gange den anbefalede dosis, forekom der reaktioner på injektionsstedet karakteriseret ved erytem og ødem.
English: Tailor the dose of Zycortal and the concurrently administered glucocorticoid replacement therapy to the individual dog based on clinical response and normalization of Na⁺ and K⁺ serum concentrations.
Danish: Dosis af Zycortal og den samtidigt administrerede glukokortikoiderstatningsbehandling skal tilpasses den enkelte hund baseret på klinisk respons og normalisering af Na⁺ og K⁺-serumkoncentrationer.
English: Initial dose of Zycortal: The initial dose is 2.2 mg/kg body weight, administered by subcutaneous injection.
Danish: Initialdosis af Zycortal: Initialdosis er 2,2 mg/kg kropsvægt indgivet ved subkutan injektion.
English: Prolonging the dosing interval:
Danish: Forlængelse af doseringsintervallet:
English: Dechra Regulatory B.V. Handelsweg 25
Danish: Dechra Regulatory B.V.
English: • Hyperkalaemia, hyponatremia or Na⁺/K⁺ ratio < 27: Decrease the Zycortal dosing interval by 2-3 days or increase the dose.
Danish: • Hyperkaliæmi, hyponatriæmi eller Na⁺/K⁺-forhold < 27: Nedsæt doseringsintervallet for Zycortal med 2-3 dage eller øg dosis.
English: • If the dog is either not clinically normal or if the Na⁺/K⁺ ratio is abnormal on Day 25, adjust the dose of glucocorticoid or Zycortal (see Subsequent doses and long term management).
Danish: • Hvis hunden enten ikke er klinisk normal, eller hvis Na⁺/K⁺-forholdet er unormalt på dag 25, justeres dosis af glukokortikoid eller Zycortal (se Efterfølgende doser og langtidsbehandling).
English: Re-evaluate the dog and measure the serum sodium/potassium ratio (Na⁺/K⁺ ratio) approximately 10 days after the first dose (which is the time to maximum concentration (Tmax) of desoxycortone).
Danish: Evaluer hunden igen og mål serum-natrium/-kalium-forholdet (Na⁺/K⁺-forholdet) ca. 10 dage efter den første dosis (hvilket er tiden til maksimal koncentration (Tmax) af desoxycorton).
English: Excipients: Chlorocresol 1 mg/ml
Danish: Hjælpestoffer: Chlorocresol 1 mg/ml
English: If the polyuria/polydipsia persists and the Na⁺/K⁺ ratio is >32, then decrease the dose of Zycortal without changing the dosing interval.
Danish: Hvis polyuri/polydipsi vedvarer, og Na⁺/K⁺-forholdet er >32, nedsættes dosis af Zycortal uden at ændre doseringsintervallet.
English: Increase dose to: 2.3 mg/kg body weight Increase dose to: 2.4 mg/kg body weight
Danish: Øg dosis til: 2,3 mg/kg kropsvægt Øg dosis til: 2,4 mg/kg kropsvægt
English: Common reactions were inappropriate urination, lethargy, alopecia, panting, vomiting, decreased appetite, anorexia, decreased activity, depression, diarrhoea, polyphagia, shaking, tiredness and urinary tract infections.
Danish: Almindelige bivirkninger var upassende urinering, sløvhed, alopeci, gispen, opkastning, manglende appetit, anoreksi, manglende aktivitet, depression, diarre, polyfagi, rysten, træthed og urinvejsinfektioner.
English: Common reactions were inappropriate urination, lethargy, alopecia (hair loss), panting, vomiting, decreased appetite, anorexia, decreased activity, depression, diarrhoea, polyphagia (excessive eating), shaking, tiredness and urinary tract infections.
Danish: Almindelige bivirkninger var upassende urinering, sløvhed, alopeci (hårtab), gispen, opkastning, manglende appetit, anoreksi, nedsat aktivitet, depression, diarre, polyfagi (øget fødeindtag), rysten, træthed og urinvejsinfektioner.
English: Continue 2.2 mg/kg body weight
Danish: Fortsæt 2,2 mg/kg kropsvægt
English: • Hypokalaemia, hypernatremia or Na⁺/K⁺ ratio > 32: Decrease the Zycortal dose.
Danish: • Hypokaliæmi, hypernatriæmi eller Na⁺/K⁺-forhold > 32: Nedsæt dosis af Zycortal.